There has been a flurry of new licensing deals in the last few days, with Bristol Myers Squibb, Sanofi, Pfizer, Roche, and little Yarrow Bioscience all adding to their R&D pipelines. BMS’ antibody alliance BMS signed a multiyear agreement with antibody specialist Harbour BioMed, which has operations in the US, the Netherlands, and China, that…
A first-of-its-kind partnership between medicines regulators in the UK and Singapore could allow patients in both countries to access new medical advances more quickly. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and Singaporean Health Sciences Authority (HSA) say the ‘regulatory innovation corridor’ aims to speed up patient access to breakthrough therapies in high-impact…
Merck KGaA has teamed up with Flagship Pioneering’s Valo Health on an ambitious project to apply AI to the discovery of novel drug targets and therapeutics for Parkinson’s disease. The partnership puts the Lexington-based biotech in line for up to $3 billion in upfront and potential milestone payments, as well as R&D funding and royalties…